{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:44:24Z","timestamp":1790721864503,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11307-013-0668-1","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T15:50:03Z","timestamp":1377618603000},"page":"274-283","source":"Crossref","is-referenced-by-count":42,"title":["Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers"],"prefix":"10.1007","volume":"16","author":[{"given":"Jinxia","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale O.","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"key":"668_CR1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00259-011-1742-z","volume":"38","author":"M Yang","year":"2011","unstructured":"Yang M, Gao H, Yan Y et al (2011) PET imaging of early response to the tyrosine kinase inhibitor ZD4190. Eur J Nucl Med Mol Imaging 38:1237\u20131247","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"668_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7150\/thno\/v01p0030","volume":"1","author":"G Niu","year":"2011","unstructured":"Niu G, Chen X (2011) Why integrin as a primary target for imaging and therapy. Theranostics 1:30\u201347","journal-title":"Theranostics"},{"key":"668_CR3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"PC Brooks","year":"1994","unstructured":"Brooks PC, Montgomery AM, Rosenfeld M et al (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157\u20131164","journal-title":"Cell"},{"issue":"Suppl 2","key":"668_CR4","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.2967\/jnumed.107.045922","volume":"49","author":"W Cai","year":"2008","unstructured":"Cai W, Chen X (2008) Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 49(Suppl 2):113S\u2013128S","journal-title":"J Nucl Med"},{"key":"668_CR5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7150\/thno.3623","volume":"2","author":"MV Backer","year":"2012","unstructured":"Backer MV, Backer JM (2012) Imaging key biomarkers of tumor angiogenesis. Theranostics 2:502\u2013515","journal-title":"Theranostics"},{"key":"668_CR6","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1681\/ASN.V7122682","volume":"7","author":"E Noiri","year":"1996","unstructured":"Noiri E, Goligorsky MS, Wang GJ et al (1996) Biodistribution and clearance of 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure. J Am Soc Nephrol 7:2682\u20132688","journal-title":"J Am Soc Nephrol"},{"key":"668_CR7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/cbr.2008.0528","volume":"23","author":"M Ahmadi","year":"2008","unstructured":"Ahmadi M, Sancey L, Briat A et al (2008) Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model. Cancer Biother Radiopharm 23:691\u2013700","journal-title":"Cancer Biother Radiopharm"},{"key":"668_CR8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2967\/jnumed.107.047423","volume":"49","author":"JM Jeong","year":"2008","unstructured":"Jeong JM, Hong MK, Chang YS et al (2008) Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 49:830\u2013836","journal-title":"J Nucl Med"},{"key":"668_CR9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00259-007-0692-y","volume":"35","author":"ZB Li","year":"2008","unstructured":"Li ZB, Chen K, Chen X (2008) (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging 35:1100\u20131108","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"668_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nucmedbio.2003.10.002","volume":"31","author":"X Chen","year":"2004","unstructured":"Chen X, Park R, Shahinian AH et al (2004) 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 31:179\u2013189","journal-title":"Nucl Med Biol"},{"key":"668_CR11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mibio.2004.06.004","volume":"6","author":"X Chen","year":"2004","unstructured":"Chen X, Liu S, Hou Y et al (2004) MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol 6:350\u2013359","journal-title":"Mol Imaging Biol"},{"key":"668_CR12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7150\/thno\/v01p0341","volume":"1","author":"L Lang","year":"2011","unstructured":"Lang L, Li W, Jia HM et al (2011) New methods for labeling RGD peptides with bromine-76. Theranostics 1:341\u2013353","journal-title":"Theranostics"},{"issue":"6","key":"668_CR13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s11307-010-0458-y","volume":"13","author":"O Jacobson","year":"2011","unstructured":"Jacobson O, Zhu L, Niu G et al (2011) MicroPET imaging of integrin alpha(v)beta (3) expressing tumors using (89)Zr-RGD peptides. Mol Imaging Biol 13(6):1224\u20131233","journal-title":"Mol Imaging Biol"},{"key":"668_CR14","first-page":"113","volume":"47","author":"X Zhang","year":"2006","unstructured":"Zhang X, Xiong Z, Wu Y et al (2006) Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 47:113\u2013121","journal-title":"J Nucl Med"},{"key":"668_CR15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnumed.110.080606","volume":"52","author":"X Sun","year":"2011","unstructured":"Sun X, Yan Y, Liu S et al (2011) 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy. J Nucl Med 52:140\u2013146","journal-title":"J Nucl Med"},{"key":"668_CR16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11307-009-0284-2","volume":"12","author":"S Liu","year":"2010","unstructured":"Liu S, Liu Z, Chen K et al (2010) 18F-labeled galacto and PEGylated RGD dimers for PET imaging of alphavbeta3 integrin expression. Mol Imaging Biol 12:530\u2013538","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"668_CR17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11307-011-0477-3","volume":"14","author":"FT Chin","year":"2012","unstructured":"Chin FT, Shen B, Liu S et al (2012) First experience with clinical-grade [(18)F]FPP(RGD) (2): an automated multi-step radiosynthesis for clinical PET studies. Mol Imaging Biol 14(1):88\u201395","journal-title":"Mol Imaging Biol"},{"key":"668_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.11101139","volume":"260","author":"ES Mittra","year":"2011","unstructured":"Mittra ES, Goris ML, Iagaru AH et al (2011) Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging alpha(v)beta(3) integrin levels. Radiology 260:182\u2013191","journal-title":"Radiology"},{"key":"668_CR19","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bc200197h","volume":"22","author":"L Lang","year":"2011","unstructured":"Lang L, Li W, Guo N et al (2011) Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjugate chemistry 22:2415\u20132422","journal-title":"Bioconjugate chemistry"},{"key":"668_CR20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/bc100137x","volume":"21","author":"WJ McBride","year":"2010","unstructured":"McBride WJ, D\u2019Souza CA, Sharkey RM et al (2010) Improved F-18 labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjugate chemistry 21:1331\u20131340","journal-title":"Bioconjugate chemistry"},{"key":"668_CR21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2967\/jnumed.108.060418","volume":"50","author":"WJ McBride","year":"2009","unstructured":"McBride WJ, Sharkey RM, Karacay H et al (2009) A novel method of F-18 radiolabeling for PET. J Nucl Med 50:991\u2013998","journal-title":"J Nucl Med"},{"key":"668_CR22","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bc200197h","volume":"22","author":"L Lang","year":"2011","unstructured":"Lang L, Li W, Guo N et al (2011) Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjugate chemistry 22:2415\u20132422","journal-title":"Bioconjugate chemistry"},{"key":"668_CR23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00259-011-2052-1","volume":"39","author":"H Gao","year":"2012","unstructured":"Gao H, Lang L, Guo N et al (2012) PET imaging of angiogenesis after myocardial infarction\/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging 39:683\u2013692","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"668_CR24","doi-asserted-by":"crossref","first-page":"e37506","DOI":"10.1371\/journal.pone.0037506","volume":"7","author":"N Guo","year":"2012","unstructured":"Guo N, Lang L, Li W et al (2012) Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model. PLoS One 7:e37506","journal-title":"PLoS One"},{"key":"668_CR25","first-page":"326","volume":"42","author":"R Haubner","year":"2001","unstructured":"Haubner R, Wester HJ, Burkhart F et al (2001) Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 42:326\u2013336","journal-title":"J Nucl Med"},{"key":"668_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno\/v01p0048","volume":"1","author":"AJ Beer","year":"2011","unstructured":"Beer AJ, Kessler H, Wester HJ, Schwaiger M (2011) PET imaging of integrin alphaVbeta3 expression. Theranostics 1:48\u201357","journal-title":"Theranostics"},{"key":"668_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/bc800455p","volume":"20","author":"J Shi","year":"2009","unstructured":"Shi J, Kim YS, Zhai S, Liu Z, Chen X, Liu S (2009) Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. Bioconjugate chemistry 20:750\u2013759","journal-title":"Bioconjugate chemistry"},{"key":"668_CR28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00259-008-1045-1","volume":"36","author":"Z Liu","year":"2009","unstructured":"Liu Z, Niu G, Shi J, Liu S, Wang F, Chen X (2009) (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Eur J Nucl Med Mol Imaging 36:947\u2013957","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"668_CR29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7150\/thno.4443","volume":"2","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Shao G, Liu S (2012) Monitoring breast tumor lung metastasis by U-SPECT-II\/CT with an integrin alpha(v)beta(3)-targeted radiotracer(99m)Tc-3P-RGD(2). Theranostics 2:577\u2013588","journal-title":"Theranostics"},{"key":"668_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/thno\/v01p0322","volume":"1","author":"J Shi","year":"2011","unstructured":"Shi J, Zhou Y, Chakraborty S et al (2011) Evaluation of in-labeled cyclic RGD peptides: effects of peptide and linker multiplicity on their tumor uptake, excretion kinetics and metabolic stability. Theranostics 1:322\u2013340","journal-title":"Theranostics"},{"key":"668_CR31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7150\/thno\/v01p0058","volume":"1","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Chakraborty S, Liu S (2011) Radiolabeled cyclic RGD peptides as radiotracers for imaging tumors and thrombosis by SPECT. Theranostics 1:58\u201382","journal-title":"Theranostics"},{"key":"668_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7150\/thno\/v01p0403","volume":"1","author":"S Liu","year":"2011","unstructured":"Liu S, Liu H, Ren G, Kimura RH, Cochran JR, Cheng Z (2011) PET imaging of integrin positive tumors using F labeled knottin peptides. Theranostics 1:403\u2013412","journal-title":"Theranostics"},{"key":"668_CR33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MMRC Tomayko","year":"1989","unstructured":"Tomayko MMRC (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148\u2013154","journal-title":"Cancer Chemother Pharmacol"},{"key":"668_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","volume":"31","author":"DMHC Euhus","year":"1986","unstructured":"Euhus DMHC, LaRegina MC, Johnson FE (1986) Tumor measurement in the nude mouse. J Surg Oncol 31:229\u2013234","journal-title":"J Surg Oncol"},{"key":"668_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.107.049452","volume":"49","author":"LM Kenny","year":"2008","unstructured":"Kenny LM, Coombes RC, Oulie I et al (2008) Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. Journal of nuclear medicine 49:879\u2013886","journal-title":"Journal of nuclear medicine"},{"key":"668_CR36","first-page":"1333","volume":"46","author":"AJ Beer","year":"2005","unstructured":"Beer AJ, Haubner R, Goebel M et al (2005) Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. Journal of nuclear medicine 46:1333\u20131341","journal-title":"Journal of nuclear medicine"},{"key":"668_CR37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214\u2013221","journal-title":"Nat Rev Drug Discov"},{"key":"668_CR38","doi-asserted-by":"crossref","first-page":"17904","DOI":"10.1073\/pnas.0906925106","volume":"106","author":"MK Gagnon","year":"2009","unstructured":"Gagnon MK, Hausner SH, Marik J, Abbey CK, Marshall JF, Sutcliffe JL (2009) High-throughput in vivo screening of targeted molecular imaging agents. Proc Natl Acad Sci U S A 106:17904\u201317909","journal-title":"Proc Natl Acad Sci U S A"},{"key":"668_CR39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/bc990167l","volume":"11","author":"LA Bass","year":"2000","unstructured":"Bass LA, Wang M, Welch MJ, Anderson CJ (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate chemistry 11:527\u2013532","journal-title":"Bioconjugate chemistry"},{"key":"668_CR40","first-page":"218","volume":"31","author":"SV Deshpande","year":"1990","unstructured":"Deshpande SV, Subramanian R, McCall MJ, DeNardo SJ, DeNardo GL, Meares CF (1990) Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. Journal of nuclear medicine 31:218\u2013224","journal-title":"Journal of nuclear medicine"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-013-0668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-013-0668-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-013-0668-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:23:36Z","timestamp":1646436216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-013-0668-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s11307-013-0668-1","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}